Alpenglow Biosciences
Alpenglow Biosciences provides AI-enabled 3D tissue imaging, digital pathology, and spatial profiling solutions for researchers and clinical teams. Its platform combines light-sheet microscopy, automated volumetric data processing, and AI-powered analysis to quantify cells, structures, and spatial relationships in intact tissue samples, supporting drug development, diagnostics, and biomarker discovery. The organization aims to advance biological insight and clinical diagnostics by enabling comprehensive analysis of tissue biology.
Facts
- HQ
- Seattle, Washington, USA
- Sectors
- Biotechnology Research
- Founded
- 2018
- Employees
- 50
- Registered name
- Alpenglow Biosciences
- Members see funding amounts. .
- Founders
- Nicholas Reder, Jonathan Liu, Adam Glaser, Larry True
Is this your organization? Claim it
William Canestaro’s Ninth Year Teaching UW Foster Health Innovation Practicum Features Wavely Diagnostics and Alpenglow Biosciences Leaders
William Canestaro returns to teach his ninth year of the Health Innovation Practicum at UW Foster, bringing entrepreneurs into class to share practical business lessons. Guest speakers Arna Ionescu Stoll (Wavely Diagnostics) and Sarah Malik (Alpenglow Biosciences) emphasized product-market fit, listening to customers, and clear investor-facing vision, while students showed strong engagement.
GeekWire 2026 Innovation of the Year Finalists Include Alpenglow Biosciences and Pacific Northwest National Laboratory
The 2026 GeekWire Awards announced finalists for Innovation of the Year, including Alpenglow Biosciences, Pacific Northwest National Laboratory, RevealDx, Starcloud, and VerAvanti, recognized for breakthroughs in healthcare and data center technology. The awards event will be held on May 7 in Seattle, with public voting open through April 10.
Alpenglow Biosciences Partners with PathNet to Commercialize 3D Microscope Tech for Cancer Diagnostics with $250K Funding
Seattle-based Alpenglow Biosciences partnered with PathNet to commercialize its 3D microscope technology for cancer diagnostics, focusing on prostate and bladder cancers. The startup also secured $250,000 in funding from Mike Rice to support regulatory validation and clinical application development.
See all 7 stories, episodes and videos about Alpenglow Biosciences.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
See all 4-
Nicholas Reder Executive Officer, Director, CEO, Founder & Co-Inventor
-
Adam Glaser Co-founder
-
Jonathan Liu Co-founder